Pustular psoriasis. Photo by Roland Tanglao via Wikimedia Commons Cutaneous paradoxical reactions to biologic therapies for psoriasis and atopic dermatitis are emerging as an important, if unpredictable, complication of these otherwise highly targeted treatments, according to Dr. Jeffrey Marcus Cohen . In a report in the Dec. 2025 issue of The Chronicle of Skin & Allergy , Dr. Cohen noted monoclonal antibodies have transformed care by addressing the underlying immunology of c

Photo by James Heilman, MD, via Wikimedia Commons Advocates, clinicians, researchers, and patients from around the world are preparing...

Photo by: Produnis via Wikimedia Commons Early research suggests a compound derived from bacteria significantly slows the progression of...

South Korean researchers report that a skin seeding technique (SST) may help children with intractable vitiligo who do not show adequate...

A new study has utilized multimodal analyses of skin affected by vitiligo in an attempt to provide some answers regarding why white...

New findings suggest the development of cutaneous immune-related adverse events (cirAEs) is associated with better treatment efficacy and...

Individuals with skin diseases including atopic dermatitis (AD), psoriasis, vitiligo and chronic urticaria (CU) are not at elevated risk...

An online survey of nearly 41,000 people in the U.S. has concluded that the prevalence of vitiligo may be much higher than reported. The...